Deep learning assisted multi-omics integration for survival and drug-response prediction in breast cancer

[1] Ferlay J(2015)Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012 Int J Cancer 136 E359-E386

[2] Soerjomataram I(2009)Global trends in breast cancer incidence and mortality Salud Publica Mex 51 s141-s146

[3] Dikshit R(2013)Epidemiological correlates of breast cancer in South India Asian Pac J Cancer Prev 14 5077-5083

[4] Eser S(2014)Breast cancer patient stratification using a molecular regularized consensus clustering method Methods 67 304-312

[5] Mathers C(2017)Dynamic strategy for personalized medicine: An application to metastatic breast cancer J Biomed Inform 68 50-57

[6] Rebelo M(2000)A gene expression database for the molecular pharmacology of cancer Nat Genet 24 236-244

[7] Parkin DM(2001)Chemosensitivity prediction by transcriptional profiling Proc Natl Acad Sci U S A 98 10787-10792

[8] Forman D(2006)Oncogenic pathway signatures in human cancers as a guide to targeted therapies Nature 439 353-357

[9] Bray F(2011)Trial watch: phase II failures: 2008-2010 Nat Rev Drug Discov 10 328-329

[10] Porter PL(2013)Clinical approval success rates for investigational cancer drugs Clin Pharmacol Ther 94 329-335

[1] Ferlay J(2015)Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012 Int J Cancer 136 E359-E386

[2] Soerjomataram I(2009)Global trends in breast cancer incidence and mortality Salud Publica Mex 51 s141-s146

[3] Dikshit R(2013)Epidemiological correlates of breast cancer in South India Asian Pac J Cancer Prev 14 5077-5083

[4] Eser S(2014)Breast cancer patient stratification using a molecular regularized consensus clustering method Methods 67 304-312

[5] Mathers C(2017)Dynamic strategy for personalized medicine: An application to metastatic breast cancer J Biomed Inform 68 50-57

[6] Rebelo M(2000)A gene expression database for the molecular pharmacology of cancer Nat Genet 24 236-244

[7] Parkin DM(2001)Chemosensitivity prediction by transcriptional profiling Proc Natl Acad Sci U S A 98 10787-10792

[8] Forman D(2006)Oncogenic pathway signatures in human cancers as a guide to targeted therapies Nature 439 353-357

[9] Bray F(2011)Trial watch: phase II failures: 2008-2010 Nat Rev Drug Discov 10 328-329

[10] Porter PL(2013)Clinical approval success rates for investigational cancer drugs Clin Pharmacol Ther 94 329-335